Arteriovenous malformation (AVM) of the pancreas is a rare disorder for which treatment is recommended as it may cause development of portal hypertension and increase the risk of gastrointestinal bleeding [1 -3] . A 50-year-old man was referred to our institute for examination of epigastric pain with mild elevation of serum amylase (143 U/L). There was no history of hemorrhagic diseases for the patient or his family. Using dynamic computed tomography (CT), an AVM was recognized at the pancreatic tail, and the return from the splenic vein was visible during the arterial phase (• " Fig. 1 a, b ). Color Doppler images from endoscopic ultrasonography (EUS) demonstrated numerous turbulent flows in the patchy hypoechoic parenchyma suggesting accompanying pancreatitis (• " Fig. 2 a) . No variceal lesion was recognized during upper gastrointestinal endoscopy, nor was any extrapancreatic AVM identified by truncal CT or brain magnetic resonance imaging (MRI). Informed consent was obtained, and the patient chose careful follow-up. Over the ensuing months, the patient's symptoms diminished and the serum amylase level normalized spontaneously. After 15 months, dynamic CT showed that the pancreatic AVM had disappeared (• " Fig. 1 c, d) , and this was confirmed by EUS 6 months after that (• " Fig. 2 b) .
Up till 2012, 81 cases of pancreatic AVM had been reported [3] . Symptoms included gastrointestinal bleeding (49 %) and abdominal and/or back pain (48 %), whereas 13/81 (16 %) were asymptomatic cases. Treatments including surgical resection (62 %), transarterial embolization (17 %), and irradiation (2 %) were performed in the majority of cases. Meanwhile, 9/13 (69 %) asymptomatic cases were followed without treatment. To date, from a PubMed keyword survey, there has been no report of pancreatic AVM spontaneously disappearing during follow-up. Although further reliable evidence is needed, careful follow-up under fully informed consent may be feasible in cases of pancreatic AVM with a low risk of gastrointestinal bleeding.
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